Skip to content
Disclosery

ANTIPODES PARTNERS Ltd: BKD position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of ANTIPODES PARTNERS Ltd on BKD, newest first. How the timeline and the estimate are built.

ANTIPODES PARTNERS Ltd held 11,091,757 BKD shares at 2026-06-30 per its 13F-HR filed 2026-08-06.

the latest 13F is the newest step

  1. period ended2026-06-30
    13F 11,091,757 shares
    Change vs previous 13F -315,057 shares

    3.27% of the 13F portfolio, value $178,466,370.

    13F-HR 0001652442-26-000005 filed by ANTIPODES PARTNERS Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2026-03-31
    13F 11,406,814 shares
    Change vs previous 13F -22,020 shares

    3% of the 13F portfolio, value $156,045,216.

    13F-HR 0001652442-26-000004 filed by ANTIPODES PARTNERS Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2025-12-31
    13F 11,428,834 shares
    Change vs previous 13F -666,835 shares

    2.59% of the 13F portfolio, value $123,326,365.

    13F-HR 0001652442-26-000002 filed by ANTIPODES PARTNERS Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2025-09-30
    13F 12,095,669 shares
    Change vs previous 13F -2,056,104 shares

    2.3% of the 13F portfolio, value $102,458,046.

    13F-HR 0001652442-25-000007 filed by ANTIPODES PARTNERS Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2025-06-30
    13F 14,151,773 shares
    Change vs previous 13F +467,273 shares

    3.06% of the 13F portfolio, value $98,503,855.

    13F-HR 0002005403-25-000004 filed by ANTIPODES PARTNERS Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  6. period ended2025-03-31
    13F 13,684,500 shares
    Change vs previous 13F +6,124,238 shares

    2.68% of the 13F portfolio, value $85,671,844.

    13F-HR 0001652442-25-000003 filed by ANTIPODES PARTNERS Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  7. period ended2024-12-31
    13F 7,560,262 shares
    Change vs previous 13F +3,507,044 shares

    1.32% of the 13F portfolio, value $38,031,189.

    13F-HR 0001652442-25-000002 filed by ANTIPODES PARTNERS Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  8. period ended2024-09-30
    13F 4,053,218 shares
    Change vs previous 13F not available

    0.95% of the 13F portfolio, value $27,523,334.

    13F-HR 0001652442-24-000006 filed by ANTIPODES PARTNERS Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).